Akumin to Go Private in Deal With PE Firm Stonepeak

Dow Jones
Oct 21, 2023
 

By Ben Glickman

 

Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case.

Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin.

The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations.

Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock.

The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure.

 

Write to Ben Glickman at ben.glickman@wsj.com

 

(END) Dow Jones Newswires

October 20, 2023 17:18 ET (21:18 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10